MICHAEL SOWELL
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology with Special Qualifications in Child Neurology
- Where
- PROSPECT, KY
- NPI
- 1578561742
- Received
- $59,980 in 95 records, 2019 to 2024
- As principal investigator
- $8,375 of research payments to others in 5 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2024 | General payment | 3 | $139 |
| 2022 | General payment | 3 | $2,892 |
| 2021 | General payment | 18 | $15,619 |
| 2020 | General payment | 28 | $13,284 |
| 2019 | General payment | 43 | $28,045 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Amgen Inc. | 28 | $26,692 | 2019–2021 |
| Allergan, Inc. | 21 | $11,771 | 2020–2021 |
| ABBVIE INC. | 11 | $8,672 | 2021–2024 |
| Biohaven Pharmaceuticals, Inc. | 8 | $7,274 | 2021 |
| Teva Pharmaceuticals USA, Inc. | 7 | $3,130 | 2019–2024 |
| Lundbeck LLC | 1 | $2,000 | 2020 |
| Supernus Pharmaceuticals, Inc. | 10 | $152 | 2019–2020 |
| SK Life Science, Inc. | 1 | $85 | 2024 |
| Lilly USA, LLC | 2 | $77 | 2019 |
| Sunovion Pharmaceuticals Inc. | 2 | $44 | 2019 |
| Mallinckrodt Enterprises LLC | 1 | $22 | 2019 |
| Greenwich Biosciences, Inc. | 1 | $22 | 2020 |
| PTC Therapeutics, Inc. | 1 | $17 | 2019 |
| UCB, Inc. | 1 | $16 | 2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 31 | $50,776 |
| Travel and Lodging | 19 | $5,048 |
| Food and Beverage | 43 | $2,113 |
| Consulting Fee | 1 | $2,000 |
| Education | 1 | $42 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2024-04-17 | Teva Pharmaceuticals USA, Inc. | $27 | Food and Beverage | In-kind items and services | AJOVY Biological, Central Nervous System | 2024 | |
| 2024-04-16 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-04-12 | SK Life Science, Inc. | $85 | Food and Beverage | In-kind items and services | 2024 | ||
| 2022-03-14 | ABBVIE INC. | $1,440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-03-07 | ABBVIE INC. | $1,440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-01-20 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2021-12-06 | ABBVIE INC. | $1,440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-12-06 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-08 | ABBVIE INC. | $1,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-10-01 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-08-12 | ABBVIE INC. | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-08-12 | ABBVIE INC. | $98 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-08-12 | ABBVIE INC. | $29 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-08-12 | Biohaven Pharmaceuticals, Inc. | $8 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2021 | |
| 2021-06-25 | Biohaven Pharmaceuticals, Inc. | $14 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2021 | |
| 2021-06-22 | Biohaven Pharmaceuticals, Inc. | $3,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NURTEC ODT Drug, PRIMARY CARE | 2021 | |
| 2021-06-22 | Biohaven Pharmaceuticals, Inc. | $732 | Travel and Lodging | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2021 | |
| 2021-06-22 | Biohaven Pharmaceuticals, Inc. | $67 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2021 | |
| 2021-06-18 | Biohaven Pharmaceuticals, Inc. | $1,275 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NURTEC ODT Drug, PRIMARY CARE | 2021 | |
| 2021-06-17 | Biohaven Pharmaceuticals, Inc. | $500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NURTEC ODT Drug, PRIMARY CARE | 2021 | |
| 2021-06-17 | Amgen Inc. | $10 | Food and Beverage | In-kind items and services | Aimovig Biological, Neuroscience | 2021 | |
| 2021-03-31 | Amgen Inc. | $831 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2021 | |
| 2021-03-08 | Biohaven Pharmaceuticals, Inc. | $1,275 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NURTEC ODT Drug, PRIMARY CARE | 2021 | |
| 2021-01-08 | Allergan, Inc. | $1,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2020-09-02 | Allergan, Inc. | $1,440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-07-14 | Lundbeck LLC | $2,000 | Consulting Fee | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2020 | |
| 2020-06-26 | Amgen Inc. | $475 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2020 | |
| 2020-06-23 | Allergan, Inc. | $42 | Education | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-05-05 | Allergan, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-04-08 | Allergan, Inc. | $1,440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-03-11 | Supernus Pharmaceuticals, Inc. | $16 | Food and Beverage | Cash or cash equivalent | TROKENDI XR Drug, AED | 2020 | |
| 2020-02-26 | Greenwich Biosciences, Inc. | $22 | Food and Beverage | In-kind items and services | Epidiolex Drug, Neurology | 2020 | |
| 2020-02-10 | Allergan, Inc. | $1,920 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-02-10 | Allergan, Inc. | $39 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-02-10 | Allergan, Inc. | $17 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-02-10 | Supernus Pharmaceuticals, Inc. | $16 | Food and Beverage | Cash or cash equivalent | TROKENDI XR Drug, AED | 2020 | |
| 2020-02-10 | Allergan, Inc. | $9 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-01-25 | Allergan, Inc. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-01-25 | Allergan, Inc. | $442 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-01-25 | Allergan, Inc. | $161 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-01-25 | Allergan, Inc. | $150 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-01-25 | Allergan, Inc. | $93 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-01-25 | Allergan, Inc. | $58 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-01-25 | Allergan, Inc. | $50 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-01-25 | Allergan, Inc. | $40 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-01-25 | Allergan, Inc. | $31 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-01-25 | Allergan, Inc. | $30 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-01-25 | Allergan, Inc. | $30 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-01-24 | Allergan, Inc. | $124 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-01-22 | UCB, Inc. | $16 | Food and Beverage | In-kind items and services | Briviact Drug, Neurology | 2020 | |
| 2020-01-16 | Supernus Pharmaceuticals, Inc. | $16 | Food and Beverage | Cash or cash equivalent | TROKENDI XR Drug, AED | 2020 | |
| 2020-01-08 | Amgen Inc. | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2020 | |
| 2019-12-12 | Teva Pharmaceuticals USA, Inc. | $2,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AJOVY Drug, Central Nervous System | 2019 | |
| 2019-11-27 | Teva Pharmaceuticals USA, Inc. | $41 | Travel and Lodging | In-kind items and services | AJOVY Drug, Central Nervous System | 2019 | |
| 2019-11-20 | Supernus Pharmaceuticals, Inc. | $11 | Food and Beverage | Cash or cash equivalent | TROKENDI XR Drug, AED | 2019 | |
| 2019-11-08 | Teva Pharmaceuticals USA, Inc. | $124 | Food and Beverage | In-kind items and services | AJOVY Drug, Central Nervous System | 2019 | |
| 2019-10-31 | Supernus Pharmaceuticals, Inc. | $19 | Food and Beverage | Cash or cash equivalent | TROKENDI XR Drug, AED | 2019 | |
| 2019-10-09 | Lilly USA, LLC | $64 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-10-09 | Lilly USA, LLC | $12 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-09-17 | Supernus Pharmaceuticals, Inc. | $13 | Food and Beverage | Cash or cash equivalent | TROKENDI XR Drug, AED | 2019 | |
| 2019-08-29 | Supernus Pharmaceuticals, Inc. | $14 | Food and Beverage | Cash or cash equivalent | TROKENDI XR Drug, AED | 2019 | |
| 2019-07-30 | Amgen Inc. | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2019 | |
| 2019-07-26 | Supernus Pharmaceuticals, Inc. | $14 | Food and Beverage | Cash or cash equivalent | TROKENDI XR Drug, AED | 2019 | |
| 2019-07-15 | Amgen Inc. | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2019 | |
| 2019-07-11 | Amgen Inc. | $105 | Food and Beverage | In-kind items and services | Aimovig Biological, Neuroscience | 2019 | |
| 2019-06-05 | Amgen Inc. | $121 | Food and Beverage | In-kind items and services | Aimovig Biological, Neuroscience | 2019 | |
| 2019-05-22 | Amgen Inc. | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2019 | |
| 2019-05-22 | Amgen Inc. | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2019 | |
| 2019-05-22 | Amgen Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2019 | |
| 2019-05-17 | Amgen Inc. | $1,017 | Travel and Lodging | In-kind items and services | Aimovig Biological, Neuroscience | 2019 | |
| 2019-05-14 | Amgen Inc. | $26 | Food and Beverage | In-kind items and services | Aimovig Biological, Neuroscience | 2019 | |
| 2019-05-14 | Amgen Inc. | $17 | Food and Beverage | In-kind items and services | Aimovig Biological, Neuroscience | 2019 | |
| 2019-05-09 | Supernus Pharmaceuticals, Inc. | $12 | Food and Beverage | Cash or cash equivalent | TROKENDI XR Drug, AED | 2019 | |
| 2019-04-24 | Mallinckrodt Enterprises LLC | $22 | Food and Beverage | In-kind items and services | ACTHAR Biological, AUTOIMMUNE AND RARE DISEASE | 2019 | |
| 2019-04-05 | Teva Pharmaceuticals USA, Inc. | $342 | Food and Beverage | In-kind items and services | AJOVY Drug, Central Nervous System | 2019 | |
| 2019-04-05 | Teva Pharmaceuticals USA, Inc. | $292 | Travel and Lodging | In-kind items and services | AJOVY Drug, Central Nervous System | 2019 | |
| 2019-04-05 | Teva Pharmaceuticals USA, Inc. | $201 | Travel and Lodging | In-kind items and services | AJOVY Drug, Central Nervous System | 2019 | |
| 2019-04-04 | Amgen Inc. | $105 | Travel and Lodging | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2019 | |
| 2019-04-03 | Amgen Inc. | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2019 | |
| 2019-03-29 | Amgen Inc. | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2019 | |
| 2019-03-26 | Amgen Inc. | $60 | Travel and Lodging | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2019 | |
| 2019-03-22 | Amgen Inc. | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2019 | |
| 2019-03-22 | Amgen Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2019 | |
| 2019-03-18 | Amgen Inc. | $835 | Travel and Lodging | In-kind items and services | Aimovig Biological, Neuroscience | 2019 | |
| 2019-03-14 | Amgen Inc. | $109 | Food and Beverage | In-kind items and services | Aimovig Biological, Neuroscience | 2019 | |
| 2019-03-11 | Sunovion Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | APTIOM Drug, CNS | 2019 | |
| 2019-03-08 | Amgen Inc. | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2019 | |
| 2019-03-04 | Amgen Inc. | $20 | Food and Beverage | In-kind items and services | Aimovig Biological, Neuroscience | 2019 | |
| 2019-02-27 | PTC Therapeutics, Inc. | $17 | Food and Beverage | In-kind items and services | EMFLAZA Drug, DMD | 2019 | |
| 2019-02-19 | Amgen Inc. | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2019 | |
| 2019-02-19 | Amgen Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Aimovig Biological, Neuroscience | 2019 | |
| 2019-02-18 | Amgen Inc. | $835 | Travel and Lodging | In-kind items and services | Aimovig Biological, Neuroscience | 2019 | |
| 2019-02-12 | Amgen Inc. | $122 | Food and Beverage | In-kind items and services | Aimovig Biological, Neuroscience | 2019 | |
| 2019-01-30 | Supernus Pharmaceuticals, Inc. | $17 | Food and Beverage | Cash or cash equivalent | TROKENDI XR Drug, AED | 2019 | |
| 2019-01-25 | Sunovion Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | APTIOM Drug, CNS | 2019 |
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2019-09-12 | Allergan, Inc. | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION INCOR | $4,253 | A PHASE 3, MULTICENTER, RANDONIMZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTIPLE ATTACK CROSSOVER STUDY TO EVAULATE THE EF | 2019 |
| 2019-09-12 | Allergan, Inc. | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION INCOR | $429 | A PHASE 3, MULTICENTER, RANDONIMZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTIPLE ATTACK CROSSOVER STUDY TO EVAULATE THE EF | 2019 |
| 2019-09-12 | Allergan, Inc. | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION INCOR | $429 | A PHASE 3, MULTICENTER, RANDONIMZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTIPLE ATTACK CROSSOVER STUDY TO EVAULATE THE EF | 2019 |
| 2019-09-12 | Allergan, Inc. | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION INCOR | $2,835 | A PHASE 3, MULTICENTER, RANDONIMZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTIPLE ATTACK CROSSOVER STUDY TO EVAULATE THE EF | 2019 |
| 2019-09-12 | Allergan, Inc. | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION INCOR | $429 | A PHASE 3, MULTICENTER, RANDONIMZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTIPLE ATTACK CROSSOVER STUDY TO EVAULATE THE EF | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Prospect, KY, county Jefferson County, KY, state Kentucky; placed by its city name.
| Measure | Place (city or town) Prospect, KY | County Jefferson County, KY | State Kentucky |
|---|---|---|---|
| Population B01003 | 4,542 | 783,022 | 4,534,824 |
| Population, 2020 census P1 | 4,592 | 782,969 | 4,505,836 |
| Median age B01002 | 54.5 | 38.4 | 39.1 |
| Under 18 B01001 | 18.6% | 22.3% | 22.6% |
| 65 and over B01001 | 30.5% | 17.2% | 17.3% |
| Households B11001 | 1,958 | 331,554 | 1,814,469 |
| Foreign born B05002 | 6.0% | 10.0% | 4.7% |
| Median household income B19013 | $163,462 | $69,866 | $63,726 |
| Median family income B19113 | $189,841 | $90,606 | $81,505 |
| Per capita income B19301 | $101,504 | $42,087 | $35,821 |
| Poverty rate B17001 | 2.4% | 14.3% | 16.1% |
| Unemployment rate B23025 | 4.2% | 5.2% | 4.9% |
| Civilian labor force B23025 | 2,222 | 409,977 | 2,152,038 |
| Mean commute (minutes) B08013 | 22.4 | 22.2 | 24.0 |
| Bachelor's degree or higher B15003 | 74.4% | 37.0% | 27.6% |
| Housing units B25001 | 2,088 | 359,710 | 2,023,116 |
| Owner-occupied B25003 | 93.3% | 62.1% | 68.3% |
| Renters B25003 | 6.7% | 37.9% | 31.7% |
| Median home value B25077 | $538,400 | $248,400 | $205,600 |
| Median gross rent B25064 | $1,193 | $1,149 | $967 |
| White, not Hispanic B03002 | 89.4% | 62.0% | 81.5% |
| Black B03002 | 4.5% | 20.6% | 7.6% |
| Hispanic or Latino B03002 | 0.4% | 8.6% | 5.0% |
| Asian B03002 | 4.2% | 3.1% | 1.6% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Economy now FRED unemployment 4.7% in Sep 2026 (4.5% a year earlier); per capita personal income $60,835 in 2025, up 29% in five years (+3.9% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Prospect, KY.
Comments